Research Reports from University Hospitals Birmingham NHS Foundation Trust Provide New Insights into Remdesivir (Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir...).

Předmět:	POLIO VIRUS diseases SARS-CoV-2 REMDESIVIR UNIVERSITY hospitals
Zdroj:	NewsRx COVID-19 Weekly; 3/20/2023, p1024-1024, 1p
Abstrakt:	Keywords: Antivirals; Biological Products; COVID-19; Coronavirus; Drugs and Therapies; Enterovirus; Genetics; Health and Medicine; Immunization; Immunology; Musculoskeletal Diseases and Conditions; Pharmaceuticals; Picornaviridae; Poliomyelitis; Poliovirus; RNA Viruses; Remdesivir Therapy; Respiratory Tract Diseases and Conditions; Risk and Prevention; SARS; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe Acute Respiratory Syndrome Coronavirus 2; Vaccines; Viral; Viral RNA; Virology EN Antivirals Biological Products COVID-19 Coronavirus Drugs and Therapies Enterovirus Genetics Health and Medicine Immunization Immunology Musculoskeletal Diseases and Conditions Pharmaceuticals Picornaviridae Poliomyelitis Poliovirus RNA Viruses Remdesivir Therapy Respiratory Tract Diseases and Conditions Risk and Prevention SARS SARS-CoV-2 Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Viral Viral RNA Virology 1024 1024 1 03/23/23 20230320 NES 230320 2023 MAR 20 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- Investigators publish new report on Remdesivir. For more information on this research see: Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu